INCLINE VILLAGE, Nev.
May 8, 2012
/PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that
John P. McLaughlin
, the company's president and chief executive officer, is scheduled to present at the following upcoming conferences:
Eleventh Annual JMP Securities Research Conference
Tuesday, May 15, 2012
9:00 a.m. PDT
San Francisco, CA
Goldman Sachs 33rd Annual Global Healthcare Conference
Thursday, June 7, 2012
8:00 a.m. PDT
Rancho Palos Verdes, CA
These presentations will be available to interested parties through live and archived audio webcasts. To access the live and subsequently archived webcasts of the presentation, go to the Company's website at
and go to "Company Presentations & Events." Please connect to the website at least 15 minutes prior to the events to allow for any software download that may be necessary. The archived webcasts will be available for seven days following each presentation.
About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new royalty bearing assets and maximizing the value of its patent portfolio and related assets. For more information, please visit
NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.
SOURCE PDL BioPharma, Inc.